Published in J Clin Endocrinol Metab on February 01, 2010
Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med (2013) 9.87
The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev (2012) 2.71
Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr (2011) 2.65
Vitamin D for health: a global perspective. Mayo Clin Proc (2013) 2.41
Antibacterial effects of vitamin D. Nat Rev Endocrinol (2011) 2.03
Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients (2013) 1.81
Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler Thromb Vasc Biol (2010) 1.69
A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J Clin Endocrinol Metab (2010) 1.59
Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol (2013) 1.58
Vitamin D and immune function. Nutrients (2013) 1.57
Association between serum vitamin D deficiency and knee osteoarthritis. Int Orthop (2010) 1.50
A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab (2014) 1.34
Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol (2012) 1.32
Plasma 25-hydroxyvitamin D during pregnancy and small-for-gestational age in black and white infants. Ann Epidemiol (2012) 1.24
Vitamin D in acute stress and critical illness. Curr Opin Clin Nutr Metab Care (2012) 1.19
The impact of vitamin D status on periodontal surgery outcomes. J Dent Res (2011) 1.18
20-hydroxyvitamin D₃ inhibits proliferation of cancer cells with high efficacy while being non-toxic. Anticancer Res (2012) 1.18
Prevalence and predictors of vitamin D deficiency in healthy adults. Endocr Pract (2012) 1.17
High prevalence of hypovitaminosis D in pregnant Japanese women with threatened premature delivery. J Bone Miner Metab (2011) 1.15
Vitamin D and mucosal immune function. Curr Opin Gastroenterol (2010) 1.15
Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One (2013) 1.14
Evidence-based D-bate on health benefits of vitamin D revisited. Dermatoendocrinol (2012) 1.12
Vitamin D in HIV-Infected Patients. Curr HIV/AIDS Rep (2011) 1.11
Diet, genetics, and disease: a focus on the middle East and north Africa region. J Nutr Metab (2012) 1.10
Vitamin D status among Adult Saudi Females visiting Primary Health Care Clinics. Int J Health Sci (Qassim) (2012) 1.09
Environment and the inflammatory bowel diseases. Can J Gastroenterol (2013) 1.07
First-trimester maternal vitamin D status and risk for gestational diabetes (GDM) a nested case-control study. Diabetes Metab Res Rev (2012) 1.07
A 12-week double-blind randomized clinical trial of vitamin D₃ supplementation on body fat mass in healthy overweight and obese women. Nutr J (2012) 1.06
Maternal vitamin D status and the risk of mild and severe preeclampsia. Epidemiology (2014) 1.05
Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection. J Clin Endocrinol Metab (2012) 1.04
Vitamin d and susceptibility of chronic lung diseases: role of epigenetics. Front Pharmacol (2011) 1.03
The biology and pathology of vitamin D control in bone. J Cell Biochem (2010) 1.03
Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women. Thyroid (2014) 1.01
Cytochrome P450-mediated metabolism of vitamin D. J Lipid Res (2013) 1.00
Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation. Biochem Biophys Res Commun (2011) 1.00
Alfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopenia. J Bone Miner Metab (2011) 0.99
Vitamin D and bone disease. Biomed Res Int (2012) 0.98
Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D: analysis by mathematical modeling. PLoS One (2012) 0.97
Variability in free 25(OH) vitamin D levels in clinical populations. J Steroid Biochem Mol Biol (2013) 0.97
Bone assessment in children with chronic kidney disease: data from two new bone imaging techniques in a single-center pilot study. Pediatr Nephrol (2011) 0.94
Updates on osteonecrosis of the jaw. Curr Opin Support Palliat Care (2010) 0.94
The status of serum vitamin D in patients with rheumatoid arthritis and undifferentiated inflammatory arthritis compared with controls. Rheumatol Int (2011) 0.93
The epidemiology of sarcopenia in community living older adults: what role does lifestyle play? J Cachexia Sarcopenia Muscle (2011) 0.92
VDR haploinsufficiency impacts body composition and skeletal acquisition in a gender-specific manner. Calcif Tissue Int (2011) 0.92
Vitamin D and chronic kidney disease. Korean J Intern Med (2014) 0.91
Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease. Front Immunol (2015) 0.91
Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters. Asian J Androl (2012) 0.91
Can we trust untargeted metabolomics? Results of the metabo-ring initiative, a large-scale, multi-instrument inter-laboratory study. Metabolomics (2014) 0.91
Vitamin D deficiency is a risk factor for obesity and diabetes type 2 in women at late reproductive age. Aging (Albany NY) (2013) 0.91
Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo. Cell Cycle (2013) 0.89
Is vitamin d insufficiency associated with mortality of critically ill patients? Crit Care Res Pract (2013) 0.89
Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D₃ load in Japanese subjects. J Bone Miner Metab (2010) 0.89
Vitamin D Deficiency and Pain: Clinical Evidence of Low Levels of Vitamin D and Supplementation in Chronic Pain States. Pain Ther (2015) 0.89
Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS. J Steroid Biochem Mol Biol (2014) 0.88
In vivo activation of the intracrine vitamin D pathway in innate immune cells and mammary tissue during a bacterial infection. PLoS One (2010) 0.88
Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study. Osteoporos Int (2012) 0.87
CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells. World J Gastroenterol (2013) 0.87
Vitamin D treatment improves survival and infant lung structure after intra-amniotic endotoxin exposure in rats: potential role for the prevention of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol (2014) 0.87
Prevalence of 25-OH vitamin D deficiency in a population of hemodialysis patients and efficacy of an oral ergocalciferol supplementation regimen. Am J Nephrol (2013) 0.87
Vitamin D status and breast cancer in Saudi Arabian women: case-control study. Am J Clin Nutr (2013) 0.87
Whether vitamin D3 is effective in reducing proteinuria in type 2 diabetic patients? J Res Med Sci (2013) 0.86
25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol (2012) 0.86
Bone mineral density status in urolithiasis patients with vitamin D inadequacy followed at a tertiary stone centre. Can Urol Assoc J (2014) 0.86
1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure. PLoS One (2015) 0.85
Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation. Kidney Int Suppl (2011) (2011) 0.85
Analysis of stress fractures in athletes based on our clinical experience. World J Orthop (2011) 0.85
A review on vitamin d deficiency treatment in pediatric patients. J Pediatr Pharmacol Ther (2013) 0.85
Immunomodulation by vitamin D: implications for TB. Expert Rev Clin Pharmacol (2011) 0.85
Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature. Exp Ther Med (2011) 0.85
Vitamin D in rheumatoid arthritis-towards clinical application. Nat Rev Rheumatol (2015) 0.85
Regulation of the extrarenal CYP27B1-hydroxylase. J Steroid Biochem Mol Biol (2013) 0.84
Vitamin d in the general population of young adults with autism in the faroe islands. J Autism Dev Disord (2014) 0.84
Cellular calcium dynamics in lactation and breast cancer: from physiology to pathology. Am J Physiol Cell Physiol (2013) 0.84
A Randomised, Double-Blinded, Placebo-Controlled, Parallel Study of Vitamin D3 Supplementation with Different Schemes Based on Multiples of 25,000 IU Doses. Int J Endocrinol (2013) 0.84
Rickets: Part I. Pediatr Radiol (2012) 0.84
Vitamin D deficiency in neovascular versus nonneovascular age-related macular degeneration. Retina (2014) 0.84
Vitamin D and Pain: Vitamin D and Its Role in the Aetiology and Maintenance of Chronic Pain States and Associated Comorbidities. Pain Res Treat (2015) 0.83
Associations between vitamin D-binding protein isotypes, circulating 25(OH)D levels, and vitamin D metabolite uptake in colon cancer cells. Cancer Prev Res (Phila) (2014) 0.83
Vitamin D₃supplementation and childhood diarrhea: a randomized controlled trial. Pediatrics (2013) 0.83
Vitamin D metabolism in human bone marrow stromal (mesenchymal stem) cells. Metabolism (2013) 0.83
Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dené First Nations cohort. PLoS One (2012) 0.83
High-dose cholecalciferol supplementation significantly increases peripheral CD4⁺ Tregs in healthy adults without negatively affecting the frequency of other immune cells. Eur J Nutr (2013) 0.83
Oral administration of a gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression. Cancer Prev Res (Phila) (2013) 0.82
Calcium and vitamin D in the regulation of energy balance: where do we stand? Int J Mol Sci (2014) 0.82
Clinical implications of vitamin D deficiency. Prz Menopauzalny (2015) 0.82
Is vitamin d deficiency a new risk factor for cardiovascular disease? Open Cardiovasc Med J (2015) 0.82
Changes in the calcium-parathyroid hormone-vitamin d axis and prognosis for critically ill patients: a prospective observational study. PLoS One (2013) 0.82
Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function. Pediatr Nephrol (2012) 0.82
Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy. Nutr J (2015) 0.82
Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort. Lupus Sci Med (2015) 0.82
Chemopreventive and chemotherapeutic effect of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model. Oncotarget (2014) 0.81
Elevated 1- α hydroxylase activity in monocytes from patients with active tuberculosis. Clin Dev Immunol (2013) 0.81
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study. PLoS One (2013) 0.81
Association between serum vitamin D status and health-related quality of life (HRQOL) in an older Korean population with radiographic knee osteoarthritis: data from the Korean national health and nutrition examination survey (2010-2011). Health Qual Life Outcomes (2015) 0.81
Association of serum 25-hydroxyvitamin D levels with markers for metabolic syndrome in the elderly: a repeated measure analysis. J Korean Med Sci (2012) 0.81
The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer. BMC Cancer (2015) 0.81
Vitamin D Deficiency and Survival in Children after Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant (2015) 0.81
Regulation of Mycobacterium-specific mononuclear cell responses by 25-hydroxyvitamin D3. PLoS One (2011) 0.81
Vitamin D deficiency in women with polycystic ovary syndrome. Clin Exp Reprod Med (2014) 0.81
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74
Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med (2009) 6.84
Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr (2008) 6.26
Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int (1997) 5.82
Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 5.63
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43
Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med (2009) 4.93
Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab (2008) 4.61
Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol (2007) 4.44
Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab (2004) 3.71
Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol (2008) 3.43
Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab (2007) 3.36
Assessing the vitamin D status of the US population. Am J Clin Nutr (2008) 2.75
Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol (2008) 2.70
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. J Invest Dermatol (2007) 2.45
Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol (2009) 2.45
Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med (2008) 2.44
Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys (2007) 2.39
A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst (2007) 2.34
Endocrine functions of bone in mineral metabolism regulation. J Clin Invest (2008) 2.19
Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One (2009) 2.14
Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol (2008) 2.05
Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res (2008) 2.00
Vitamin D: a D-Lightful health perspective. Nutr Rev (2008) 1.87
Low maternal vitamin D status and fetal bone development: cohort study. J Bone Miner Res (2010) 1.80
IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol (2008) 1.79
Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res (2009) 1.66
Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab (2008) 1.65
Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr (2008) 1.60
Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology (2008) 1.58
Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab (2009) 1.51
Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients. Endocr Pract (2008) 1.48
25-Hydroxyvitamin D: functional outcomes in infants and young children. Am J Clin Nutr (2008) 1.48
Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology (2008) 1.44
Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res (2009) 1.38
Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol Reprod (2008) 1.37
Structural analysis of CYP2R1 in complex with vitamin D3. J Mol Biol (2008) 1.33
IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J Immunol (2008) 1.31
Vitamin D2 formation from post-harvest UV-B treatment of mushrooms (Agaricus bisporus) and retention during storage. J Agric Food Chem (2008) 1.27
Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. Endocr Pract (2009) 1.24
Back to the future: a new look at 'old' vitamin D. J Endocrinol (2008) 1.20
1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol (2008) 1.19
Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J Clin Endocrinol Metab (2009) 1.17
Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis. PLoS One (2009) 1.17
Vitamin D and innate immunity. Curr Opin Investig Drugs (2008) 1.15
Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up. Ann Nutr Metab (2008) 0.98
Leptin attenuates gene expression for renal 25-hydroxyvitamin D3-1alpha-hydroxylase in mice via the long form of the leptin receptor. Arch Biochem Biophys (2007) 0.97
Vitamin D regulation of cathelicidin in the skin: toward a renaissance of vitamin D in dermatology? J Invest Dermatol (2008) 0.89
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74
Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab (2008) 4.61
Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat (2005) 4.14
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev (2004) 3.56
Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med (2011) 3.27
Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol (2009) 2.45
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science (2013) 2.34
1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol (2009) 2.22
Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol (2002) 2.02
Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J Bone Miner Res (2002) 1.94
Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol (2004) 1.89
Vitamin D and placental-decidual function. J Soc Gynecol Investig (2004) 1.79
IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol (2008) 1.79
Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab (2010) 1.72
Vitamin D in defense of the human immune response. Ann N Y Acad Sci (2007) 1.63
Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet (2003) 1.58
Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res (2005) 1.58
Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod (2006) 1.57
Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe (2009) 1.55
Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology (2010) 1.51
1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis (2009) 1.51
Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab (2010) 1.48
Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol (2005) 1.45
Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization. Endocrinology (2008) 1.45
Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology (2008) 1.44
T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A (2010) 1.42
The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol (2002) 1.41
Vitamin D: beyond bone. Ann N Y Acad Sci (2013) 1.39
Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int (2008) 1.36
Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J Biol Chem (2005) 1.26
25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab (2002) 1.24
Back to the future: a new look at 'old' vitamin D. J Endocrinol (2008) 1.20
Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res (2013) 1.17
Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation. Arthritis Res Ther (2006) 1.17
Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy. Am J Pathol (2004) 1.17
Vitamin D and the regulation of placental inflammation. J Immunol (2011) 1.13
Vitamin D metabolism and innate immunity. Mol Cell Endocrinol (2011) 1.11
Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. Proc Natl Acad Sci U S A (2003) 1.06
Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling. FASEB J (2010) 1.05
Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol (2013) 1.03
Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-β₁ in patients with chronic kidney disease. Nephron Clin Pract (2011) 1.00
Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation (2005) 0.99
Identification of VDR-responsive gene signatures in breast cancer cells. Oncology (2007) 0.99
Response element binding proteins and intracellular vitamin D binding proteins: novel regulators of vitamin D trafficking, action and metabolism. J Steroid Biochem Mol Biol (2004) 0.99
Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study. Nephron Clin Pract (2007) 0.98
Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D: analysis by mathematical modeling. PLoS One (2012) 0.97
Prereceptor regulation of glucocorticoid action by 11beta-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation. FASEB J (2002) 0.97
A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. J Clin Endocrinol Metab (2002) 0.97
Hormone response element binding proteins: novel regulators of vitamin D and estrogen signaling. Steroids (2011) 0.95
Expression of 11beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells. Blood (2005) 0.95
Vitamin D bioavailability and catabolism in pediatric chronic kidney disease. Pediatr Nephrol (2013) 0.94
11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol. Endocr Res (2002) 0.92
Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy. PLoS One (2013) 0.91
Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response. J Bone Miner Res (2007) 0.91
Functional characterization of heterogeneous nuclear ribonuclear protein C1/C2 in vitamin D resistance: a novel response element-binding protein. J Biol Chem (2006) 0.91
Vitamin D activation of functionally distinct regulatory miRNAs in primary human osteoblasts. J Bone Miner Res (2013) 0.91
Dietary vitamin D restriction in pregnant female mice is associated with maternal hypertension and altered placental and fetal development. Endocrinology (2013) 0.90
Androgen receptor-mediated regulation of the alpha-subunit of the epithelial sodium channel in human kidney. Hypertension (2005) 0.89
Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells. Arthritis Rheum (2012) 0.89
1alpha-hydroxylase and innate immune responses to 25-hydroxyvitamin D in colonic cell lines. J Steroid Biochem Mol Biol (2010) 0.88
Vitamin D-mediated hypercalcemia in slack skin disease: evidence for involvement of extrarenal 25-hydroxyvitamin D 1alpha-hydroxylase. J Bone Miner Res (2006) 0.88
Vitamin D: a new player in the world of mTOR signaling. Cell Cycle (2011) 0.86
Control of estradiol-directed gene transactivation by an intracellular estrogen-binding protein and an estrogen response element-binding protein. Mol Endocrinol (2007) 0.86
Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene. Hypertension (2003) 0.85
19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia. Cancer Res (2005) 0.85
Immunomodulation by vitamin D: implications for TB. Expert Rev Clin Pharmacol (2011) 0.85
11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone. J Clin Endocrinol Metab (2003) 0.84
Vitamin D and microRNAs in bone. Crit Rev Eukaryot Gene Expr (2013) 0.83
Glucocorticoid-induced apoptosis in human decidua: a novel role for 11beta-hydroxysteroid dehydrogenase in late gestation. J Endocrinol (2007) 0.83
Serum- and glucocorticoid-regulated kinase isoform-1 and epithelial sodium channel subunits in human ocular ciliary epithelium. Invest Ophthalmol Vis Sci (2003) 0.83
Hormones and immune function: implications of aging. Aging Cell (2004) 0.82
Dietary vitamin D intake in advanced CKD/ESRD. Semin Dial (2010) 0.82
Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation. J Clin Endocrinol Metab (2012) 0.81
Beyond mineral metabolism, is there an interplay between FGF23 and vitamin D in innate immunity? Pediatr Nephrol (2012) 0.80
Association studies between the HSD11B2 gene (encoding human 11beta-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathy. Eur J Endocrinol (2002) 0.80
Mechanisms of decreased Vitamin D 1alpha-hydroxylase activity in prostate cancer cells. Mol Cell Endocrinol (2004) 0.79
An Hsp27-related, dominant-negative-acting intracellular estradiol-binding protein. J Biol Chem (2004) 0.79
Estradiol and tamoxifen mediate rescue of the dominant-negative effects of estrogen response element-binding protein in vivo and in vitro. Endocrinology (2008) 0.79
Cloning of a functional 25-hydroxyvitamin D-1α-hydroxylase in zebrafish (Danio rerio). Cell Biochem Funct (2014) 0.78
Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function. Eur J Endocrinol (2005) 0.77
Report of the CCFA pediatric bone, growth and muscle health workshop, New York City, November 11-12, 2011, with updates. Inflamm Bowel Dis (2013) 0.77
Vitamin D-mediated hypercalcemia and Cushing syndrome as manifestations of malignant pleural mesothelioma. Endocr Pract (2008) 0.77
Renal PPARγ mRNA expression increases with impairment of renal function in patients with chronic kidney disease. Nephrology (Carlton) (2010) 0.77
Adenosine 5'-triphosphate-dependent vitamin D sterol binding to heat shock protein-70 chaperones. Endocrinology (2005) 0.77
Hypercalcemia associated with mineral oil-induced sclerosing paraffinomas. Endocr Pract (2013) 0.76
A role for vitamin D in placental immunology. J Infect Dis (2010) 0.75
Immunodetection of 11β-Hydroxysteroid Dehydrogenase Type 2 in Human Mineralocorticoid Target Tissues: Evidence for Nuclear Localization. Endocrinology (1997) 0.75